文献速递肺外科

肺叶切除术后同侧解剖性切除治疗肺癌的手术结局

Surgical outcome of ipsilateral anatomical resection for lung cancer after pulmonary lobectomy.
PubMed 文献 · Eur J Cardiothorac Surg · 2023-01-01

该多中心回顾性研究分析了2012年1月至2018年12月间51例肺叶切除术后同侧解剖性切除肺癌患者的围术期结局与总生存,并与3411例无同侧肺叶切除史的I期肺癌解剖性切除患者比较。结果显示同侧再手术并发症频率较高,但c-I期NSCLC患者5年总生存率83.5%,与无既往肺叶切除者相比生存无显著差异。

要点

  • 肺叶切除术后同侧解剖性切除包括10例全肺切除、19例肺叶切除和22例肺段切除。
  • 手术时间312.2±134.5分钟,术中出血522.2±797.5毫升。
  • c-I期NSCLC再切除后5年总生存率83.5%,与无既往肺叶切除者生存相当。

核心结论

  • 肺叶切除术后同侧解剖性切除与较高的术中及术后并发症发生率相关,但c-I期NSCLC患者5年总生存率与无既往肺叶切除者相当。

研究设计与样本

  • 多中心回顾性研究,纳入2012年1月至2018年12月间51例肺叶切除术后同侧解剖性切除的肺癌患者,并与3411例无同侧肺叶切除史的I期肺癌解剖性切除患者比较。

主要发现

  • 同侧解剖性切除包括10例全肺切除、19例肺叶切除和22例肺段切除。
  • 手术时间312.2±134.5分钟,术中出血522.2±797.5毫升。
  • 术中并发症9例,术后并发症15例。
  • 解剖性切除后5年总生存率为83.5%。
  • c-I期NSCLC患者中,有同侧肺叶切除史者与无既往肺叶切除者相比生存无显著差异。

关键数值与推荐

  • c-I期NSCLC有同侧肺叶切除史者5年总生存率83.5%。
  • 术中并发症9例,术后并发症15例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Ipsilateral reoperation after pulmonary lobectomy is often challenging because of adhesions from the previous operation. We retrospectively examined the surgical outcome and prognosis of ipsilateral anatomical resection for lung cancer after pulmonary lobectomy using a multicentre database. METHODS: We evaluated the perioperative outcomes and overall survival of 51 patients who underwent pulmonary lobectomy followed by ipsilateral anatomical resection for lung cancer between January 2012 and December 2018. In addition, patients with stage I non-small-cell lung cancer (NSCLC) were compared with 3411 patients with stage I lung cancer who underwent pulmonary resection without a prior ipsilateral lobectomy. RESULTS: Ipsilateral anatomical resections included 10 completion pneumonectomies, 19 pulmonary lobectomies and 22 pulmonary segmentectomies. Operative time was 312.2 ± 134.5 min, and intraoperative bleeding was 522.2 ± 797.5 ml. Intraoperative and postoperative complications occurred in 9 and 15 patients, respectively. However, the 5-year overall survival rate after anatomical resection followed by ipsilateral lobectomy was 83.5%. Furthermore, in patients with c-stage I NSCLC, anatomical resection followed by ipsilateral lobectomy was not associated with worse survival than anatomical resection without prior ipsilateral lobectomy. CONCLUSIONS: Anatomical resection following ipsilateral lobectomy is associated with a high frequency of intraoperative and postoperative complications. However, the 5-year overall survival in patients with c-stage I NSCLC who underwent ipsilateral anatomical resection after pulmonary lobectomy is comparable to that in patients who underwent anatomical resection without prior pulmonary lobectomy.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Okazaki M, Suzawa K, Shien K, et al. Surgical outcome of ipsilateral anatomical resection for lung cancer after pulmonary lobectomy. Eur J Cardiothorac Surg. 2023. PMID: 36752515. doi:10.1093/ejcts/ezad048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。